RT Journal Article
SR Electronic
T1 EULAR recommendations for the management of large vessel vasculitis
JF Annals of the Rheumatic Diseases
JO Ann Rheum Dis
FD BMJ Publishing Group Ltd and European League Against Rheumatism
SP 318
OP 323
DO 10.1136/ard.2008.088351
VO 68
IS 3
A1 C Mukhtyar
A1 L Guillevin
A1 M C Cid
A1 B Dasgupta
A1 K de Groot
A1 W Gross
A1 T Hauser
A1 B Hellmich
A1 D Jayne
A1 C G M Kallenberg
A1 P A Merkel
A1 H Raspe
A1 C Salvarani
A1 D G I Scott
A1 C Stegeman
A1 R Watts
A1 K Westman
A1 J Witter
A1 H Yazici
A1 R Luqmani
A1 for the European Vasculitis Study Group
YR 2009
UL http://ard.bmj.com/content/68/3/318.abstract
AB Objectives: To develop European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis.Methods: An expert group (10 rheumatologists, 3 nephrologists, 2 immunolgists, 2 internists representing 8 European countries and the USA, a clinical epidemiologist and a representative from a drug regulatory agency) identified 10 topics for a systematic literature search through a modified Delphi technique. In accordance with standardised EULAR operating procedures, recommendations were derived for the management of large vessel vasculitis. In the absence of evidence, recommendations were formulated on the basis of a consensus opinion.Results: Seven recommendations were made relating to the assessment, investigation and treatment of patients with large vessel vasculitis. The strength of recommendations was restricted by the low level of evidence and EULAR standardised operating procedures.Conclusions: On the basis of evidence and expert consensus, management recommendations for large vessel vasculitis have been formulated and are commended for use in everyday clinical practice.